Pricing Log in Create free account

Akanda Corp. (AKAN) vs Redhill Biopharma Ltd. (RDHL)

Akanda Corp. and Redhill Biopharma Ltd. are both Drug Manufacturers Specialty & Generic companies. Redhill Biopharma Ltd. is the larger, with a market value of $3.8M against $2.2M — 1.7× the size. Across the 6 metrics below, Akanda Corp. leads on 4 and Redhill Biopharma Ltd. on 2.

Valuation

Metric AKAN RDHL Drug Manufacturers Specialty & Generic median
P/E — n/m 20.55
P/S — 0.00 2.08
P/B n/m n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 6.43 2.87
Earnings yield — (142,015.51%) (15.94%)
Free cash flow yield 0.00% (231,394.02%) 0.00%

Profitability

Metric AKAN RDHL Drug Manufacturers Specialty & Generic median
Gross margin — 35.16% 53.51%
Operating margin — 0.00% 0.00%
Net margin — 25.20% (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.80%)
Return on assets 0.00% 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN RDHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (61.93%) 5.22%
EPS growth (last fiscal year) (139.63%) 97.91% 42.91%
Revenue growth, 5-year CAGR 161.77% (66.15%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN RDHL Drug Manufacturers Specialty & Generic median
Debt to equity (0.70) 0.00 0.04
Current ratio 0.22 0.34 2.41
Net debt to EBITDA (2.75) 0.53 1.01

Dividend

Metric AKAN RDHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric AKAN RDHL Drug Manufacturers Specialty & Generic median
Market cap 2.24m 3.79m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack